IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Omega Fund Management, LLC

Q1 2018 Holdings

Filed 2018-05-04 | 12 holdings | $101.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Paratek PharmaceuticalsCommon Stock699374302$33.8K2,600,41033.2%
Sienna Biopharmaceuticals(SNNAQ)Common Stock82622H108$14.2K758,61014.0%
ObsEvaCommon StockH5861P103$13.5K1,000,00013.3%
Jounce Therapeutics(JNCEEUR)Common Stock481116101$11.8K529,96511.6%
CymaBay Therapeutics(CBAYUSD)Common Stock23257D103$7.2K551,4777.0%
FibroGen(FGENEUR)Common Stock31572Q808$6.0K130,6465.9%
Pieris PharmaceuticalsCommon Stock720795103$5.3K778,2305.2%
Essa PharmaCommon Stock29668H104$4.1K21,696,9694.1%
Dicerna Pharmaceuticals(DRNAUSD)Common Stock253031108$2.1K223,4572.1%
EgaletCommon Stock28226B104$1.8K2,889,9261.8%
Cidara TherapeuticsCommon Stock171757107$1.8K444,9651.7%
Juno TherapeuticsCommon Stock48205A109$000.0%